The Measurement Gap: Why Most Plan Sponsors Are Flying Blind on Metabolic Health

Employers receive more health plan data today than at any point in the history of employer-sponsored benefits. Claims reports are delivered monthly. Pharmacy utilization reports are reviewed quarterly. Actuarial projections are prepared before renewal meetings. Yet with all of that information, many plan sponsors still cannot answer one of the most important questions in healthcare management: is the covered population becoming healthier over time?

That question is difficult to answer because most health plan reporting is designed to explain spending after it occurs. It can identify what was billed, what was paid, which conditions generated the highest costs, and which medications drove pharmacy trend. Those reports are useful, but they are fundamentally retrospective.

Metabolic Health Exposes the Weakness

The measurement gap becomes especially clear in metabolic health. Many of the most expensive conditions affecting employer-sponsored health plans are connected to metabolic dysfunction, including obesity, Type 2 diabetes, cardiovascular disease, hypertension, sleep apnea, kidney disease, and musculoskeletal complications. These conditions often develop gradually over many years before appearing as major claims events.

What Is Missing

What is missing is not more data. Most employers already have more data than they can use effectively. What is missing is a way to organize health information around a clear longitudinal question: is metabolic risk improving or deteriorating across the covered population? The Metabolic Health Index (MHI) was developed to address this missing layer of healthcare measurement.